Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The femoral vein puncture site refers to an anatomical area—typically 1 to 2 cm inferior to the inguinal ligament and medial to the femoral artery—where the common femoral vein is accessed for clinical procedures such as central venous cannulation, drug delivery, or diagnostic interventions. The femoral vein lies within the femoral triangle, which is bounded by the inguinal ligament (superior), adductor longus muscle (medial), and sartorius muscle (lateral). The femoral vein is the main deep vein of the thigh, draining blood from the lower limb into the external iliac vein. Procedures targeting this site are anatomical and not molecular; they do not interact with receptors, enzymes, transporters, or other canonical drug targets. This entry is incorrect as a molecular target because it refers exclusively to a vascular access location and not to a biological molecule, protein, or receptor. If you need detailed information on the femoral vein itself as a structure, refer to canonical anatomical sources, but it is not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Femoral vein puncture site.